TY - JOUR
T1 - Impact of Comorbid Dementia on Patterns of Hospice Use
AU - Aldridge, Melissa D.
AU - Hunt, Lauren
AU - Husain, Mohammed
AU - Li, Lihua
AU - Kelley, Amy
N1 - Funding Information:
NIA R01AG054540 and NIA K24AG062785 (Kelley); NINR R01 NR018462 and NIA K07 AG060270 (Aldridge); Claude D. Pepper Older Americans Independence Center; KL2 TR001870 and National Palliative Care Research Center Career Development Award (Hunt); and NIA PO1 AG066605 (Aldridge, Kelley).
Funding Information:
The HRS is a national longitudinal study of adults 51 years of age and older in the contiguous United States funded by the National Institute on Aging (grant number NIA U01AG009740) and the Social Security Administration and conducted by the University of Michigan since 1992. Serial interviews are done every two years and response rates for each interview wave have exceeded 86%. These interviews include detailed questions on the participant’s demographic and social characteristics, functional and cognitive status, medical information, caregiving needs and hours of support, and financial information. The HRS also completes post-death interviews with a knowledgeable proxy. HRS obtains consent from respondents with fee-for-service (FFS) Medicare to link to their Medicare Claims data.
Publisher Copyright:
© 2022, Mary Ann Liebert, Inc., publishers 2022.
PY - 2022/3
Y1 - 2022/3
N2 - Background: The evidence base for understanding hospice use among persons with dementia is almost exclusively based on individuals with a primary terminal diagnosis of dementia. Little is known about whether comorbid dementia influences hospice use patterns. Objective: To estimate the prevalence of comorbid dementia among hospice enrollees and its association with hospice use patterns. Design: Pooled cross-sectional analysis of the nationally representative Health and Retirement Study (HRS) linked to Medicare claims. Subjects: Fee-for-service Medicare beneficiaries in the United States who enrolled with hospice and died between 2004 and 2016. Measurements: Dementia was assessed using a validated survey-based algorithm. Hospice use patterns were enrollment less than or equal to three days, enrollment greater than six months, hospice disenrollment, and hospice disenrollment after six months. Results: Of 3123 decedents, 465 (14.9%) had a primary hospice diagnosis of dementia and 943 (30.2%) had comorbid dementia and died of another illness. In fully adjusted models, comorbid dementia was associated with increased odds of hospice enrollment greater than six months (adjusted odds ratio [AOR] = 1.52, 95% confidence interval [CI]: 1.11-2.09) and hospice disenrollment following six months of hospice (AOR = 2.55, 95% CI: 1.43-4.553). Having a primary diagnosis of dementia was associated with increased odds of hospice enrollment greater than six months (AOR = 2.62, 95% CI: 1.86-3.68), hospice disenrollment (AOR = 1.82, 95% CI: 1.32-2.51), and hospice disenrollment following six months of hospice (AOR = 4.31, 95% CI: 2.37-7.82). Conclusion: Approximately 45% of the hospice population has primary or comorbid dementia and are at increased risk for long hospice enrollment periods and hospice disenrollment. Consideration of the high prevalence of comorbid dementia should be inherent in hospice staff training, quality metrics, and Medicare Hospice Benefit policies.
AB - Background: The evidence base for understanding hospice use among persons with dementia is almost exclusively based on individuals with a primary terminal diagnosis of dementia. Little is known about whether comorbid dementia influences hospice use patterns. Objective: To estimate the prevalence of comorbid dementia among hospice enrollees and its association with hospice use patterns. Design: Pooled cross-sectional analysis of the nationally representative Health and Retirement Study (HRS) linked to Medicare claims. Subjects: Fee-for-service Medicare beneficiaries in the United States who enrolled with hospice and died between 2004 and 2016. Measurements: Dementia was assessed using a validated survey-based algorithm. Hospice use patterns were enrollment less than or equal to three days, enrollment greater than six months, hospice disenrollment, and hospice disenrollment after six months. Results: Of 3123 decedents, 465 (14.9%) had a primary hospice diagnosis of dementia and 943 (30.2%) had comorbid dementia and died of another illness. In fully adjusted models, comorbid dementia was associated with increased odds of hospice enrollment greater than six months (adjusted odds ratio [AOR] = 1.52, 95% confidence interval [CI]: 1.11-2.09) and hospice disenrollment following six months of hospice (AOR = 2.55, 95% CI: 1.43-4.553). Having a primary diagnosis of dementia was associated with increased odds of hospice enrollment greater than six months (AOR = 2.62, 95% CI: 1.86-3.68), hospice disenrollment (AOR = 1.82, 95% CI: 1.32-2.51), and hospice disenrollment following six months of hospice (AOR = 4.31, 95% CI: 2.37-7.82). Conclusion: Approximately 45% of the hospice population has primary or comorbid dementia and are at increased risk for long hospice enrollment periods and hospice disenrollment. Consideration of the high prevalence of comorbid dementia should be inherent in hospice staff training, quality metrics, and Medicare Hospice Benefit policies.
KW - comorbidity
KW - dementia
KW - end of life
KW - health services research
KW - hospice
UR - http://www.scopus.com/inward/record.url?scp=85122299928&partnerID=8YFLogxK
U2 - 10.1089/jpm.2021.0055
DO - 10.1089/jpm.2021.0055
M3 - Article
C2 - 34665050
AN - SCOPUS:85122299928
SN - 1096-6218
VL - 25
SP - 396
EP - 404
JO - Journal of Palliative Medicine
JF - Journal of Palliative Medicine
IS - 3
ER -